Supernus Pharmaceuticals Inc (SUPN)

Dec 12, 2025

(SUPN) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

Dec 12, 2025

Dec 05, 2025

Can Supernus Pharmaceuticals Inc. stock resist market sell offsRate Hike & Scalable Portfolio Growth Ideas - Newser

Dec 05, 2025

Dec 03, 2025

Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Popularity With Investors Is Under Threat From Overpricing - 富途牛牛

Dec 03, 2025

Dec 03, 2025

Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics ... - Enidnews.com

Dec 03, 2025

Dec 03, 2025

Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference - GlobeNewswire

Dec 03, 2025

Dec 02, 2025

Supernus Pharmaceuticals, Inc. (SUPN) Stock Forecasts - Yahoo! Finance Canada

Dec 02, 2025

Nov 30, 2025

Responsive Playbooks and the SUPN Inflection - news.stocktradersdaily.com

Nov 30, 2025

Nov 30, 2025

Is Supernus Pharmaceuticals Inc. stock overvalued by current metricsDay Trade & Free Accurate Trade Setup Notifications - moha.gov.vn

Nov 30, 2025

Nov 30, 2025

Supernus Pharmaceuticals Inc Stock Analysis and ForecastMerger & Acquisition Updates & Buy Sell Signal Notifications - earlytimes.in

Nov 30, 2025

Nov 30, 2025

Reversal Confirmed Inter Globe Finance Limited Stock Rallies Above MAStock Price Forecasts & High Return Capital Gain - earlytimes.in

Nov 30, 2025

Nov 28, 2025

Supernus Pharmaceuticals (SUPN) Is Down 17.4% After Raising 2025 Guidance Amid Margin and Supply Pressures – Has the Bull Case Changed? - Sahm

Nov 28, 2025

Nov 27, 2025

Is Supernus Pharmaceuticals Inc a good long term investmentChart Pattern Recognition & Small Budget Trading Portfolio - earlytimes.in

Nov 27, 2025

Nov 27, 2025

What analysts say about Supernus Pharmaceuticals Inc stockEconomic Data Impact & Outstanding Return Stocks - earlytimes.in

Nov 27, 2025

Nov 24, 2025

SUPN insider Form 4 shows 15,000-share option exercise at $12.98 - Stock Titan

Nov 24, 2025

Nov 24, 2025

Assessing Supernus Pharmaceuticals After FDA Pipeline News and 24% Jump in 2025 - Yahoo Finance

Nov 24, 2025

Nov 24, 2025

Healthcare Stocks Analysis 2025: COO & SUPN to Sell, HCA to BuyNews and Statistics - IndexBox

Nov 24, 2025

Nov 22, 2025

Assessing Supernus Pharmaceuticals (SUPN) Valuation as Shares Hold Steady Following Period of Range-Bound Trading - Sahm

Nov 22, 2025

Nov 22, 2025

Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times

Nov 22, 2025

Nov 21, 2025

Branded Pharmaceuticals Stocks Q3 Results: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN) - Yahoo Finance

Nov 21, 2025

Nov 21, 2025

How Supernus Pharmaceuticals Inc. stock benefits from tech adoptionJuly 2025 Update & Expert Curated Trade Ideas - newser.com

Nov 21, 2025

Nov 20, 2025

Supernus to acquire depression drugmaker Sage - MSN

Nov 20, 2025

Nov 20, 2025

Why Supernus Pharmaceuticals Inc. stock could benefit from AI revolutionQuarterly Trade Summary & Growth Focused Entry Point Reports - newser.com

Nov 20, 2025

Nov 19, 2025

Understanding the Setup: (SUPN) and Scalable Risk - news.stocktradersdaily.com

Nov 19, 2025

Nov 19, 2025

Advanced analytics toolkit walkthrough for Supernus Pharmaceuticals Inc.Sell Signal & Expert Approved Trade Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Statistical indicators supporting Supernus Pharmaceuticals Inc.’s strengthJuly 2025 Earnings & Fast Moving Stock Watchlists - newser.com

Nov 19, 2025

Nov 19, 2025

Measuring Supernus Pharmaceuticals Inc.’s beta against major indices2025 Dividend Review & Technical Confirmation Trade Alerts - newser.com

Nov 19, 2025

Nov 17, 2025

Is Supernus Pharmaceuticals Inc. a candidate for recovery playJuly 2025 Price Swings & Capital Efficient Trade Techniques - newser.com

Nov 17, 2025

Nov 17, 2025

How Investors Are Reacting To Supernus Pharmaceuticals (SUPN) Raising 2025 Revenue Guidance Despite Net Losses - simplywall.st

Nov 17, 2025

Nov 17, 2025

Supernus at Jefferies Conference: Strategic Growth and Challenges By Investing.com - Investing.com Australia

Nov 17, 2025

Nov 17, 2025

SUPN: Strong CNS portfolio growth, supply challenges for Onapgo, and active business development focus - TradingView

Nov 17, 2025

Nov 17, 2025

[Form 4] SUPERNUS PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan

Nov 17, 2025

Nov 15, 2025

Long term hold vs stop loss in Supernus Pharmaceuticals Inc.2025 Macro Impact & Technical Confirmation Alerts - newser.com

Nov 15, 2025

Nov 15, 2025

Using data models to predict Supernus Pharmaceuticals Inc. stock movementJobs Report & Weekly Momentum Stock Picks - newser.com

Nov 15, 2025

Nov 15, 2025

How to monitor Supernus Pharmaceuticals Inc. with trend dashboardsWeekly Investment Summary & Community Consensus Stock Picks - newser.com

Nov 15, 2025